-transparent.png){kind=logo}
This meeting was attended by several hundred delegates and covered, in lecture and poster presentations, recent developments in basic, applied and clinical research as they concern antiviral drug development for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Below are summaries of presentations that are relevant to the development of antiviral drug resistance. Copyright 2000 Harcourt Publishers Ltd.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Robert W. King
February 1996,
Journal of the International Association of Physicians in AIDS Care,
Robert W. King
January 1999,
Antiviral therapy,
Robert W. King
January 2011,
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002),
Robert W. King
January 1975,
Developments in biological standardization,
Robert W. King
January 2018,
AIDS reviews,
Robert W. King
January 1998,
Antiviral therapy,
Robert W. King
March 1996,
Nursing praxis in New Zealand inc,
Robert W. King
September 2005,
The Lancet. Infectious diseases,
Robert W. King
September 2008,
The journal of evidence-based dental practice,
Robert W. King
March 2012,
Journal of inorganic biochemistry,
